AI-Pathway Companion
Actionable insights for personalized care
Our vision
To optimize care pathways with an intelligent decision support system aimed at facilitating diagnosis and therapeutic decisions along disease-specific pathways.
As today’s healthcare delivery system continues to accelerate and evolve key stakeholders from hospital executives to clinicians, are faced with a growing number of challenges in the enabling and sustaining of outcomes-based healthcare. Data overload, interoperability, physician burnout, and overall rising cost of care serve as barriers in the disruption of precise diagnosis, prognosis, and treatment-driven patient outcomes.
Product vision
Keeping patients at the center of it all
Leveraging data integration and augmented intelligence technologies, the solution AI-Pathway Companion with its applications, aims to support your multidisciplinary experts’ team to ease clinical and operational decisions. AI-Pathway Companion applications enable personalized and standardized patient management and offer process improvement insights through analysis of key performance indicators. The AI-Pathway Companion product suite helps in patient-centric clinical and operational decisions along disease-specific care pathways using augmented intelligence, data integration, and insights from cohort analytics.
Our goals for the AI-Pathway Companion product suite:
- AI-Pathway Companion enables automatic patient-specific mapping along the clinical pathway using evidence-based guidelines4-7
- AI-Pathway Companion facilitates objective decision-making by multi-disciplinary experts on correlated patient data and preferences4, 6
- AI-Pathway Companion offers transparent insights into time to diagnosis and treatment8
- AI-Pathway Companion provides process improvement insights through cohort analysis of performance indicators8
Benefits
AI-Pathway Companion applications are not commercially available in all countries. Their future availability cannot be guaranteed. AI-Pathway Companion Prostate Cancer is CE-compliant in accordance with Directive 93/42/EEC. AI-Pathway Companion Analytics and AI-Pathway Companion Connector are not intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.
1Institute of Medicine. 2013. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: The National Academies Press.
2Overtreatment in the United States, 2017 lyu et al.
3University of Iowa, Carver College of Medicine report, 2014.
4This function is supported by AI-Pathway Companion Prostate Cancer.
5Prerequisite: “All data is available as required per guideline.”; Feature dependent on quality of input data.
6AI-Pathway Companion Prostate Cancer VA10A supports prostate cancer adenocarcinoma cases only.
7AI-Pathway Companion Prostate Cancer VA10A supports NCCN guidelines. EAU guideline support under development.
8This function is supported by AI-Pathway Companion Analytics.
9This function is supported by AI-Pathway Companion Connector.
10NLP supported languages: English, German